Study of the Active Components and Molecular Mechanism of Tripterygium wilfordii in the Treatment of Diabetic Nephropathy

We aimed to explore the active ingredients and molecular mechanism of Tripterygium wilfordii (TW) in the treatment of diabetic nephropathy (DN) through network pharmacology and molecular biology. First, the active ingredients and potential targets of TW were obtained through the Traditional Chinese...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Lin, Wang, Zheyi, Yang, Zhihua, Yang, Kang, Yang, Hongtao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8215273/
https://www.ncbi.nlm.nih.gov/pubmed/34164430
http://dx.doi.org/10.3389/fmolb.2021.664416
_version_ 1783710215899709440
author Wang, Lin
Wang, Zheyi
Yang, Zhihua
Yang, Kang
Yang, Hongtao
author_facet Wang, Lin
Wang, Zheyi
Yang, Zhihua
Yang, Kang
Yang, Hongtao
author_sort Wang, Lin
collection PubMed
description We aimed to explore the active ingredients and molecular mechanism of Tripterygium wilfordii (TW) in the treatment of diabetic nephropathy (DN) through network pharmacology and molecular biology. First, the active ingredients and potential targets of TW were obtained through the Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform (TCMSP) and related literature materials, and Cytoscape 3.7.2 software was used to construct the active ingredient-target network diagram of TW. Second, the target set of DN was obtained through the disease database, and the potential targets of TW in the treatment of DN were screened through a Venn diagram. A protein interaction network diagram (PPI) was constructed with the help of the String platform and Cytoscape 3.7.2. Third, the ClueGO plug-in tool was used to enrich the GO biological process and the KEGG metabolic pathway. Finally, molecular docking experiments and cell pathway analyses were performed. As a result, a total of 52 active ingredients of TW were screened, and 141 predicted targets and 49 target genes related to DN were identified. The biological process of GO is mediated mainly through the regulation of oxygen metabolism, endothelial cell proliferation, acute inflammation, apoptotic signal transduction pathway, fibroblast proliferation, positive regulation of cyclase activity, adipocyte differentiation and other biological processes. KEGG enrichment analysis showed that the main pathways involved were AGE-RAGE, vascular endothelial growth factor, HIF-1, IL-17, relaxin signalling pathway, TNF, Fc epsilon RI, insulin resistance and other signaling pathways. It can be concluded that TW may treat DN by reducing inflammation, reducing antioxidative stress, regulating immunity, improving vascular disease, reducing insulin resistance, delaying renal fibrosis, repairing podocytes, and reducing cell apoptosis, among others, with multicomponent, multitarget and multisystem characteristics.
format Online
Article
Text
id pubmed-8215273
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-82152732021-06-22 Study of the Active Components and Molecular Mechanism of Tripterygium wilfordii in the Treatment of Diabetic Nephropathy Wang, Lin Wang, Zheyi Yang, Zhihua Yang, Kang Yang, Hongtao Front Mol Biosci Molecular Biosciences We aimed to explore the active ingredients and molecular mechanism of Tripterygium wilfordii (TW) in the treatment of diabetic nephropathy (DN) through network pharmacology and molecular biology. First, the active ingredients and potential targets of TW were obtained through the Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform (TCMSP) and related literature materials, and Cytoscape 3.7.2 software was used to construct the active ingredient-target network diagram of TW. Second, the target set of DN was obtained through the disease database, and the potential targets of TW in the treatment of DN were screened through a Venn diagram. A protein interaction network diagram (PPI) was constructed with the help of the String platform and Cytoscape 3.7.2. Third, the ClueGO plug-in tool was used to enrich the GO biological process and the KEGG metabolic pathway. Finally, molecular docking experiments and cell pathway analyses were performed. As a result, a total of 52 active ingredients of TW were screened, and 141 predicted targets and 49 target genes related to DN were identified. The biological process of GO is mediated mainly through the regulation of oxygen metabolism, endothelial cell proliferation, acute inflammation, apoptotic signal transduction pathway, fibroblast proliferation, positive regulation of cyclase activity, adipocyte differentiation and other biological processes. KEGG enrichment analysis showed that the main pathways involved were AGE-RAGE, vascular endothelial growth factor, HIF-1, IL-17, relaxin signalling pathway, TNF, Fc epsilon RI, insulin resistance and other signaling pathways. It can be concluded that TW may treat DN by reducing inflammation, reducing antioxidative stress, regulating immunity, improving vascular disease, reducing insulin resistance, delaying renal fibrosis, repairing podocytes, and reducing cell apoptosis, among others, with multicomponent, multitarget and multisystem characteristics. Frontiers Media S.A. 2021-06-07 /pmc/articles/PMC8215273/ /pubmed/34164430 http://dx.doi.org/10.3389/fmolb.2021.664416 Text en Copyright © 2021 Wang, Wang, Yang, Yang and Yang. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Molecular Biosciences
Wang, Lin
Wang, Zheyi
Yang, Zhihua
Yang, Kang
Yang, Hongtao
Study of the Active Components and Molecular Mechanism of Tripterygium wilfordii in the Treatment of Diabetic Nephropathy
title Study of the Active Components and Molecular Mechanism of Tripterygium wilfordii in the Treatment of Diabetic Nephropathy
title_full Study of the Active Components and Molecular Mechanism of Tripterygium wilfordii in the Treatment of Diabetic Nephropathy
title_fullStr Study of the Active Components and Molecular Mechanism of Tripterygium wilfordii in the Treatment of Diabetic Nephropathy
title_full_unstemmed Study of the Active Components and Molecular Mechanism of Tripterygium wilfordii in the Treatment of Diabetic Nephropathy
title_short Study of the Active Components and Molecular Mechanism of Tripterygium wilfordii in the Treatment of Diabetic Nephropathy
title_sort study of the active components and molecular mechanism of tripterygium wilfordii in the treatment of diabetic nephropathy
topic Molecular Biosciences
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8215273/
https://www.ncbi.nlm.nih.gov/pubmed/34164430
http://dx.doi.org/10.3389/fmolb.2021.664416
work_keys_str_mv AT wanglin studyoftheactivecomponentsandmolecularmechanismoftripterygiumwilfordiiinthetreatmentofdiabeticnephropathy
AT wangzheyi studyoftheactivecomponentsandmolecularmechanismoftripterygiumwilfordiiinthetreatmentofdiabeticnephropathy
AT yangzhihua studyoftheactivecomponentsandmolecularmechanismoftripterygiumwilfordiiinthetreatmentofdiabeticnephropathy
AT yangkang studyoftheactivecomponentsandmolecularmechanismoftripterygiumwilfordiiinthetreatmentofdiabeticnephropathy
AT yanghongtao studyoftheactivecomponentsandmolecularmechanismoftripterygiumwilfordiiinthetreatmentofdiabeticnephropathy